Bioactive Compounds Against SARS-CoV-2

Coronaviruses can cause illness, severe disease, and death; e.g. Middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS), and COVID-19. Vaccine development and antiviral drugs are challenged by the propensity for viral mutations allowing these viruses to evade such therapies. There are a number of bioactive compounds from natural sources, which can exert health benefits and act as antiviral therapies such as anti-inflammation, anti-oxidative stress, and immune regulation. This book summarizes research on the potential efficacy and underlying mechanisms of bioactive compounds and traditional medicines against SARS-CoV-2. Key Features Summarizes the potential benefits of bioactive therapies for coronaviruses. Focuses on COVID-19, but also covers MERS and SARS. Provides alternatives to vaccines and other antiviral drugs whose efficacy is reduced by viral mutations. Relevant for clinicians and public health officials.

General

Imprint:	Taylor & Francis
Country of origin:	United Kingdom
Release date:	September 2023
First published:	2024
Editors:	Jen Tsung Chen
Dimensions:	280 x 210mm (L x W)
Pages:	276
ISBN-13:	978-1-03-234799-8
Categories:	Books
LSN:	1-03-234799-6
Barcode:	9781032347998

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!